ArticleNucleic acids research2026
Small regulatory RNAs modulate lactococcal susceptibility to cell wall-targeting antimicrobials.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
The contribution of small RNAs to the regulation of cell wall defence mechanisms-crucial for protecting bacteria from environmental insults-remains poorly understood in Lactococcus cremoris, a model organism for studying lactic acid bacteria. Characterization of the profiles of 193 putative small regulatory RNAs (sRNAs), including 131 newly identified in this study, revealed altered expression of 20 and 25 sRNAs following treatment with cell wall-targeting antimicrobials, lysozyme and penicillin G, respectively. Further analysis and genome-wide functional screening identified four sRNAs that affected lysozyme response in opposite directions: elevated levels of sLLM1042+, sLLM2-, and sLLM1993+ were associated with increased resistance, whereas sLLM461+ with decreased resistance. Moreover, elevated expression of sLLM2-, sLLM1042+, or both promoted sensitivity to penicillin G and certain abiotic stresses, and exerted pleiotropic effects on gene regulation at both RNA and protein levels, suggesting broader regulatory impacts. Notably, the sLLM2- mediated decrease in four putative tellurium resistance proteins resulted in increased sensitivity to tellurite stress. As sLLM2- mutations, altering lysozyme and penicillin responses, also reduced alanine racemase Alr expression, we suggest that sRNA upregulation modulates D-alanine levels, thereby affecting lipoteichoic acid modification or peptidoglycan synthesis. Our findings support a contribution of sRNAs to LAB responses to cell wall-targeting antimicrobials.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.